G1 Therapeutics Inc Stock Forecast
G1 Therapeutics Inc stock downgraded from Hold/Accumulate to Sell Candidate after Wednesday trading session.
(Updated on Apr 24, 2024)
The G1 Therapeutics Inc stock price fell by -4.77% on the last day (Wednesday, 24th Apr 2024) from $4.19 to $3.99. During the last trading day the stock fluctuated 7.49% from a day low at $3.94 to a day high of $4.24. The price has fallen in 7 of the last 10 days and is down by -14.19% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -13 thousand shares and in total, 341 thousand shares were bought and sold for approximately $1.36 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 21.52% during the next 3 months and, with a 90% probability hold a price between $3.41 and $6.12 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
GTHX Signals & Forecast
There are few to no technical positive signals at the moment. The G1 Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $4.13 and $4.06. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 09, 2024, and so far it has fallen -18.24%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for G1 Therapeutics Inc stock
On the downside, the stock finds support just below today's level from accumulated volume at $3.79 and $3.33. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, G1 Therapeutics Inc finds support just below today's level at $3.79. If this is broken, then the next support from accumulated volume will be at $3.33 and $3.32.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.295 between high and low, or 7.49%. For the last week the stock has had daily average volatility of 6.89%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (GTHX) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect G1 Therapeutics Inc to open at $4.06, and during the day (based on 14 day Average True Range), to move between $3.66 and $4.32, which gives a possible trading interval of +/-$0.329 (+/-8.24%) up or down from last closing price. If G1 Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 16.49% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $4.08 (2.26%) than the support at $3.79 (5.01%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
G1 Therapeutics Inc will release earnings BMO on Wednesday, May 01, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.190. We will update the financials statements for G1 Therapeutics Inc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 12.51% in the first trading day after earnings release.
Is G1 Therapeutics Inc stock A Buy?
The G1 Therapeutics Inc stock holds several negative signals and despite the positive trend, we believe G1 Therapeutics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -4.358 Sell Candidate Downgraded
Predicted Opening Price for G1 Therapeutics Inc of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $4.06 ( 1.63%) | $3.99 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for GTHX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 4.35 | 9.02 % | |
| R2 | 4.24 | 6.20 % | ||
| R1 | 4.17 | 4.45 % | ||
| Current price: | 3.99 | |||
| Support | S1 | 3.94 | -1.20 % | |
| S2 | 3.87 | -2.94 % | ||
| S3 | 3.76 | -5.76 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 4.70 | 17.79 % | |
| R2 | 4.54 | 13.78 % | ||
| R1 | 4.08 | 2.26 % | ||
| Current price | 3.99 | |||
| Support | S1 | 3.79 | -5.01% | |
| S2 | 3.33 | -16.54% | ||
| S3 | 3.32 | -16.79% |
FAQ
Click here for our free guide on how to buy G1 Therapeutics Inc Stock.
